Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

4.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

5.

Risk of a second cancer after early breast cancer is low, say new findings


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot